Skip to main content

Advertisement

SpringerLink
Log in

What are the real waiting times for therapeutic management of head and neck cancer: a study in the general population in the north-west of France

  • Head and Neck
  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Abstract

Head and neck cancers (HNC) have a poor prognosis and a long treatment delay may have a negative impact on this. Some studies have investigated the determinants of this delay but not in the general population and rarely taking into account socio-economic factors. A high-resolution population-based study about cancer management was conducted, using registries in the north-west of France, on HNC diagnosed between 2008 and 2010. The median time between diagnosis and multidisciplinary team meeting (DMI) (N = 1631) was 14 days (Q1: 7 to Q3: 26). The median time between diagnosis and first treatment (DTI) (N = 1519) was 35 days (Q1: 21 to Q3: 54). When the first treatment was radiotherapy, the interval was 54.5 days (Q1: 40 to Q3: 71). In multivariate analysis, DTI was associated with the type of first treatment and place of treatment. For advanced stage HNC, DTI was associated with comorbidities, topography of the cancer and socio-economic status, underprivileged patients being treated later than privileged ones. Given the French governmental cancer plans which set out to coordinate care pathways via nursing coordinators and to improve the availability of radiotherapy, the waiting times observed in this study still seem long. The optimal care pathway should include adapted social management but the DTI was still longer for underprivileged patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H et al (2013) Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 49:1374–1403

    Article  CAS  PubMed  Google Scholar 

  2. Gatta G, Botta L, Sanchez MJ, Anderson LA, Pierannunzio D, Licitra L et al (2015) Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: the EUROCARE-5 population-based study. Eur J Cancer 51:2130–2143

    Article  Google Scholar 

  3. Neal RD (2009) Do diagnostic delays in cancer matter? Br J Cancer 101(Suppl 2):S9–S12

    Article  PubMed  PubMed Central  Google Scholar 

  4. Chen Z, King W, Pearcey R, Kerba M, Mackillop WJ (2008) The relationship between waiting time for radiotherapy and clinical outcomes: a systematic review of the literature. Radiother Oncol 87:3–16

    Article  PubMed  Google Scholar 

  5. Waaijer A, Terhaard CH, Dehnad H, Hordijk GJ, van Leeuwen MS, Raaymakers CP et al (2003) Waiting times for radiotherapy: consequences of volume increase for the TCP in oropharyngeal carcinoma. Radiother Oncol 66:271–276

    Article  PubMed  Google Scholar 

  6. Jensen AR, Nellemann HM, Overgaard J (2007) Tumor progression in waiting time for radiotherapy in head and neck cancer. Radiother Oncol 84:5–10

    Article  PubMed  Google Scholar 

  7. van Harten MC, Hoebers FJ, Kross KW, van Werkhoven ED, van den Brekel MW, van Dijk BA (2015) Determinants of treatment waiting times for head and neck cancer in the Netherlands and their relation to survival. Oral Oncol 51:272–278

    Article  PubMed  Google Scholar 

  8. Caudell JJ, Locher JL, Bonner JA (2011) Diagnosis-to-treatment interval and control of locoregionally advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 137:282–285

    Article  PubMed  Google Scholar 

  9. Patel UA, Brennan TE (2012) Disparities in head and neck cancer: assessing delay in treatment initiation. Laryngoscope 122:1756–1760

    Article  PubMed  Google Scholar 

  10. Rogers SN, Pabla R, McSorley A, Lowe D, Brown JS, Vaughan ED (2007) An assessment of deprivation as a factor in the delays in presentation, diagnosis and treatment in patients with oral and oropharyngeal squamous cell carcinoma. Oral Oncol 43:648–655

    Article  CAS  PubMed  Google Scholar 

  11. Ligier K, Belot A, Launoy G, Velten M, Bossard N, Iwaz J et al (2011) Descriptive epidemiology of upper aerodigestive tract cancers in France: incidence over 1980–2005 and projection to 2010. Oral Oncol 47:302–307

    Article  PubMed  Google Scholar 

  12. Ligier K, Plouvier S, Danzon A, Martin P, Benoit E, Molinie F et al (2012) Éléments d’exhaustivité et résultats pour la première année d’enregistrement du Registre général des cancers de Lille et de sa région. Rev Epidemiol Sante Publique 60(2):131–139

    Article  CAS  PubMed  Google Scholar 

  13. Binder-Foucard F, Bossard N, Delafosse P, Belot A, Woronoff AS, Remontet L et al (2014) Cancer incidence and mortality in France over the 1980–2012 period: solid tumors. Rev Epidemiol Sante Publique 62:95–108

    Article  CAS  PubMed  Google Scholar 

  14. Velten M (2013) Tête et cou. In: Survie des personnes atteintes de cancer en France, 1989–2007—Etude à partir des registres des cancers du réseau Francim. http://www.invs.sante.fr/pmb/invs/(id)/PMB_11316. Accessed 21 January 2016

  15. INCA (2016) http://www.e-cancer.fr/Plan-cancer/Les-Plans-cancer-de-2003-a-2013. Accessed 21 January 2016

  16. Gregoire V, Lefebvre JL, Licitra L, Felip E, Group E-E-EGW (2010) Squamous cell carcinoma of the head and neck: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 21(Suppl 5):v184–v186

    Article  PubMed  Google Scholar 

  17. Cuny F, Babin E, Lacau-Saint-Guily J, Baujat B, Bensadoun R, Bozec A et al (2015) French Society of ENT (SFORL) guidelines for care pathway organization in head and neck oncology (short version). Early management of head and neck cancer. Eur Ann Otorhinolaryngol Head Neck Dis 132:205–208

    Article  CAS  PubMed  Google Scholar 

  18. Pornet C, Delpierre C, Dejardin O, Grosclaude P, Launay L, Guittet L et al (2012) Construction of an adaptable European transnational ecological deprivation index: the French version. J Epidemiol Commun Health 66:982–989

    Article  Google Scholar 

  19. Molinie F, Leux C, Delafosse P, Ayrault-Piault S, Arveux P, Woronoff AS et al (2013) Waiting time disparities in breast cancer diagnosis and treatment: a population-based study in France. Breast 22:810–816

    Article  CAS  PubMed  Google Scholar 

  20. Francim (2012) Du diagnostic au premier traitement: délais de prise en charge des cancers enregistrés par les registres sécialisés du réseau Francim 1999–2008. INCA, Boulogne-Billancourt

    Google Scholar 

  21. Lyhne NM, Christensen A, Alanin MC, Bruun MT, Jung TH, Bruhn MA et al (2013) Waiting times for diagnosis and treatment of head and neck cancer in Denmark in 2010 compared to 1992 and 2002. Eur J Cancer 49:1627–1633

    Article  CAS  PubMed  Google Scholar 

  22. Toustrup K, Lambertsen K, Birke-Sorensen H, Ulhoi B, Sorensen L, Grau C (2011) Reduction in waiting time for diagnosis and treatment of head and neck cancer—a fast track study. Acta Oncol 50:636–641

    Article  PubMed  Google Scholar 

  23. Ouwens MM, Hermens RR, Hulscher MM, Merkx MA, van den Hoogen FJ, Grol RP et al (2009) Impact of an integrated care program for patients with head and neck cancer on the quality of care. Head Neck 31:902–910

    Article  PubMed  Google Scholar 

  24. Munck K, Ali MJ, Murr AH, Goldberg AN (2005) Impact of socioeconomic status on the diagnosis to treatment interval in Waldeyer’s ring carcinoma. Laryngoscope 115:1283–1287

    Article  PubMed  Google Scholar 

  25. Lejeune C, Sassi F, Ellis L, Godward S, Mak V, Day M et al (2010) Socio-economic disparities in access to treatment and their impact on colorectal cancer survival. Int J Epidemiol 39:710–717

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

We thank the French National Cancer Institute and the Ligue Contre le Cancer of Calvados, Manche, Nord and Somme which provided financial support for this study. We thank the ENT specialists, maxillofacial surgeons, oncologists, pathologists, doctors of the health insurance funds and patient administrative database, the multidisciplinary committees, the medical secretaries and archivists of Calvados, Manche, Nord and Somme.

Author information

Authors and Affiliations

  1. Registre général des tumeurs du Calvados, Centre F Baclesse, 14000, Caen, France

    Anne-Valerie Guizard

  2. U1086 Inserm, Université Caen Basse Normandie, “Cancer et prévention”, Centre F Baclesse, 14000, Caen, France

    Anne-Valerie Guizard, Olivier Dejardin, Ludivine Launay, Emmanuel Babin & Guy Launoy

  3. Pôle de Recherche, Centre Hospitalo-universitaire de Caen, 14000, Caen, France

    Olivier Dejardin & Guy Launoy

  4. Registre des cancers de la Manche, Centre Hospitalier Public du Cotentin, 50100, Cherbourg-Octeville, France

    Simona Bara

  5. Registre du cancer de la Somme, Hôpital Nord, 80054, Amiens, France

    Bénédicte Lapôtre-Ledoux

  6. Service ORL et chirurgie cervico-faciale, Centre Hospitalo-universitaire de Caen, 14000, Caen, France

    Emmanuel Babin

  7. Registre général des cancers de Lille et sa région, GCS “Centre de Référence Régional en Cancérologie”, CHRU de LILLE, Hôpital Calmette, Pavillon Breton, Boulevard du Professeur Jules Leclercq, 59037, Lille Cedex, France

    Karine Ligier

Authors
  1. Anne-Valerie Guizard
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Olivier Dejardin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ludivine Launay
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Simona Bara
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Bénédicte Lapôtre-Ledoux
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Emmanuel Babin
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Guy Launoy
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Karine Ligier
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Karine Ligier.

Ethics declarations

Funding

This study was funded by the French National Cancer Institute and the Ligue Contre le Cancer of Calvados, Manche, Nord and Somme.

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study was authorised by the CNIL (the French national data protection agency)—no. 907276. For this type of study, formal consent is not required.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Guizard, AV., Dejardin, O., Launay, L. et al. What are the real waiting times for therapeutic management of head and neck cancer: a study in the general population in the north-west of France. Eur Arch Otorhinolaryngol 273, 3951–3958 (2016). https://doi.org/10.1007/s00405-016-4056-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-016-4056-8

Keywords

Search

Navigation